Alpha-helical antimicrobial peptides (University of Colorado)

N/A

Report date: 2023/04/14 10:50:34

Base Information

Drug NameAlpha-helical antimicrobial peptides (University of Colorado)
Drug Alias NameAlpha-helical peptide therapeutics
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVoltage-gated calcium channel blockersSerotonin 2a (5-HT2a) receptor antagonistsAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1Serotonin 2a (5-HT2a) receptorVoltage-gated calcium channel
Therapy Area/IndicationsCross Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado
Inactive CompaniesN/A
Active IndicationsCross Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A